MB, Levis & Associates’s Viatris VTRS Stock Holding History

MB, Levis & Associates’s Portfolio VTRS Stock Details VTRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$775	Buy	49 +1	+2%	+$15	﹤0.01%	244
2026 Q1	$654	Hold	48	–	–	﹤0.01%	223
2025 Q4	$598	Hold	48	–	–	﹤0.01%	237
2025 Q3	$471	Buy	48 +1	+2%	+$10	﹤0.01%	237
2025 Q2	$419	Sell	47 -278	-86%	-$2.35K	﹤0.01%	258
2025 Q1	$2.83K	Buy	325 +2	+0.6%	+$21	﹤0.01%	242
2024 Q4	$4.03K	Buy	323 +1	+0.3%	+$12	﹤0.01%	229
2024 Q3	$3.74K	Buy	322 +1	+0.3%	+$12	﹤0.01%	237
2024 Q2	$3.41K	Buy	321 +2	+0.6%	+$22	﹤0.01%	236
2024 Q1	$3.81K	Buy	319 +1	+0.3%	+$12	﹤0.01%	230
2023 Q4	$3.44K	Buy	318 +1	+0.3%	+$10	﹤0.01%	228
2023 Q3	$3.12K	Buy	317 +2	+0.6%	+$21	﹤0.01%	231
2023 Q2	$3.15K	Buy	315 +1	+0.3%	+$10	﹤0.01%	233
2023 Q1	$3.02K	Buy	314 +2	+0.6%	+$22	﹤0.01%	238
2022 Q4	$3.48K	Buy	+312	New	+$3.26K	﹤0.01%	218

Other funds holding VTRS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

MB, Levis & Associates's VTRS Position: Q2 2026 in Review

MB, Levis & Associates increased its Viatris (VTRS) stake by 2.1% in Q2 2026, buying an estimated $15 and bringing the position to 49 shares worth $775. The position accounts for ﹤0.01% of the portfolio, ranked #244.

MB, Levis & Associates first reported a position in VTRS in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.03K in Q4 2024. 1,030 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

MB, Levis & Associates held 49 shares of Viatris worth $775 as of Q2 2026.
MB, Levis & Associates bought 1 Viatris share in Q2 2026, an estimated $15.
Viatris made up ﹤0.01% of MB, Levis & Associates's portfolio in Q2 2026, its #244 holding.
MB, Levis & Associates first reported a position in Viatris in Q4 2022 and has held it in 15 quarters since.
MB, Levis & Associates's Viatris position peaked at $4.03K in Q4 2024.
1,030 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on MB, Levis & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.